162 computing-"https:" "https:" "https:" "UCL" positions at Technical University of Denmark
Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
. Further information Further information may be obtained from Prof. Ivan Mijakovic: ivmi@biosustain.dtu.dk You can read more about the hiring department at https://www.biosustain.dtu.dk/ If you are
-
of the general degree programmes at DTU. For information about our enrolment requirements and the general planning of the PhD study programme, please see DTU's rules for the PhD education . Assessment
-
Further information may be obtained from professor Ole Baltazar Andersen, phone : 45 45259754 oa(at)space.dtu.dk or professor Per Knudsen pk(at)space.dtu.dk You can read more about the division at https
-
requirements and the general planning of the PhD study programme, please see DTU's rules for the PhD education . Assessment The assessment of the applicants will be made by Professor Peter Vilhelm Skov (DTU Aqua
-
for teaching and research CV including employment history, list of publications indicating scientific highlights, H-index and ORCID (see http://orcid.org/ ) Teaching portfolio including documentation
-
Engineering & Structural Biology at https://www.biosustain.dtu.dk/research/research-areas/natural-products/enzyme-engineering-and-structural-biology If you are applying from abroad, you may find useful
-
obtained from Senior Researcher Bjarke Eltard Larsen , https://orbit.dtu.dk/en/persons/bjarke-eltard-larsen . You can read more about Department of Civil and Mechanical Engineering at www.construct.dtu.dk
-
computing- and cloud infrastructure – enabling research, innovation, and secure data-driven services across society. About DTU Computerome DTU Computerome is a national High-Performance Computing (HPC) and
-
Job Description Join a young research group dedicated to transforming materials discovery from empirical exploration to predictive design. Our research program builds on a synergy of high-throughput
-
Job Description Migraine affects more than 15% of the global population and remains inadequately treated despite advances in biologics and receptor-targeting therapies. Emerging computational